Putting the award page together from the records…
Putting the award page together from the records…
KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4).
Up for re-bid: ends 2027-03-31. Recompete brief → · CTN Data, Statistics, and Clinical Trial Support Center (DSC7) ↗
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
2 actions since 2025-07-30. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-06-25 | P00002 | Option exercised | $174.8K | KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 03/31/2027. DSC6. 75N95022F00004 (TO4). |
| 2025-07-30 | P00001 | Change order | $500.8K | KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 03/31/2027. DSC6. 75N95022F00004 (TO4). |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗